-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Abcam (NASDAQ:ABCM) Sees Strong Trading Volume
Abcam (NASDAQ:ABCM) Sees Strong Trading Volume
Abcam plc (NASDAQ:ABCM – Get Rating) saw strong trading volume on Monday . 4,040 shares were traded during mid-day trading, a decline of 98% from the previous session's volume of 162,655 shares.The stock last traded at $15.12 and had previously closed at $14.62.
Wall Street Analysts Forecast Growth
Separately, Panmure Gordon upgraded Abcam from a "hold" rating to a "buy" rating in a report on Monday, September 5th.
Get Abcam alerts:Abcam Stock Up 0.1 %
The stock has a 50 day simple moving average of $14.82 and a two-hundred day simple moving average of $15.54.
Institutional Trading of Abcam
A number of hedge funds and other institutional investors have recently bought and sold shares of ABCM. HM Payson & Co. acquired a new stake in Abcam in the fourth quarter valued at $29,000. 1832 Asset Management L.P. acquired a new stake in Abcam in the first quarter valued at $32,000. National Bank of Canada FI increased its position in shares of Abcam by 71.3% during the second quarter. National Bank of Canada FI now owns 2,777 shares of the company's stock worth $40,000 after purchasing an additional 1,156 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Abcam by 48.7% during the first quarter. JPMorgan Chase & Co. now owns 3,044 shares of the company's stock worth $56,000 after purchasing an additional 997 shares in the last quarter. Finally, Advisor Group Holdings Inc. increased its position in shares of Abcam by 20.5% during the fourth quarter. Advisor Group Holdings Inc. now owns 5,876 shares of the company's stock worth $138,000 after purchasing an additional 999 shares in the last quarter. 11.82% of the stock is currently owned by institutional investors and hedge funds.Abcam Company Profile
(Get Rating)
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools.
Read More
- Get a free copy of the StockNews.com research report on Abcam (ABCM)
- These 3 Reports Will Tell Us Much About the Current Economy
- Is Five Below Trying to Punch Too High?
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.
Abcam plc (NASDAQ:ABCM – Get Rating) saw strong trading volume on Monday . 4,040 shares were traded during mid-day trading, a decline of 98% from the previous session's volume of 162,655 shares.The stock last traded at $15.12 and had previously closed at $14.62.
週一，阿布卡姆公司(納斯達克代碼：ABCM-GET Rating)的成交量強勁。午盤成交量為4,040股，較前一交易日的162,655股減少98%。該股尾盤報15.12美元，此前收盤報14.62美元。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
Separately, Panmure Gordon upgraded Abcam from a "hold" rating to a "buy" rating in a report on Monday, September 5th.
另外，Panmure Gordon在9月5日週一的一份報告中將Abcam的評級從持有上調至買入。
Abcam Stock Up 0.1 %
Abcam股價上漲0.1%
The stock has a 50 day simple moving average of $14.82 and a two-hundred day simple moving average of $15.54.
該股的50日簡單移動均線切入位為14.82美元，200日簡單移動均線切入位為15.54美元。
Institutional Trading of Abcam
ABCAM的機構性交易
Abcam Company Profile
Abcam公司簡介
(Get Rating)
(獲取評級)
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools.
Abcam plc是一家生命科學公司，專注於識別、開發和分發用於科學研究、診斷和藥物發現的試劑和工具。它的主要產品包括一抗和二抗；結合抗體和結合試劑盒；單鏈和多重免疫分析；包括細胞因子的蛋白質和多肽；編輯的細胞系和裂解產物；以及各種其他產品，包括細胞活動試劑盒、miRNA試劑盒、生物化學品和細胞信號途徑工具。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Abcam (ABCM)
- These 3 Reports Will Tell Us Much About the Current Economy
- Is Five Below Trying to Punch Too High?
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
- 免費獲取關於abcam(ABCM)的StockNews.com研究報告
- 這三份報告將告訴我們許多關於當前經濟的情況。
- 下面的五個是不是打得太高了？
- 這就是現在對標準普爾500指數的預期
- 關於甲骨文的FQ1報告，你需要知道的兩件事
- 波動市場的三隻價值股
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.
接收abcam日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Abcam和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧